Immunomodulatory receptor LAG3 and CTLA-4 may play lesser roles in DLBCL, as no differences in LAG3 expression on immune cells in the tumor microenvironment were observed compared to heathy donors [128]. The gene discussed is LAG3; the disease is neoplasm.